Physician

David Lecompte Ross, MD

According to 2025 Medicare claims, David Ross, MD (NPI: 1912959594) practices medical oncology in the Palm Bay-Melbourne-Titusville, FL market, with the plurality of this provider's patient population coming from Brevard, FL. This provider's primary affiliated billing organization is CANCER CARE CENTERS OF BREVARD INC (NPI: 1467551762; TIN: 593169766) and primary practice location at 32955-3229. Ross is affiliated with the Primary Care Alliance, LLC (ACO ID: D0010), participating under the REACH model.

Ross' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 691 traditional Medicare patients, billed 172,014 HCPCS/CPT codes, and received $3,451,242 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,292 prescription claims across 380 beneficiaries totaling $3,522,280 in drug costs, led by Erleada (Apalutamide). 2022 DME data shows 14 claims. Open Payments data shows 188 records totaling $4,496. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,518,102 to $3,451,242. Similarly, Part D prescription costs have risen steadily, from $679,646 to $3,522,280. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $1,120 to $1,598.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.8M$3.6M2015 Medicare payment: $1,518,102 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,905,293 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,890,334 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $3,054,461 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,159,899 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,640,140 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,803,986 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,625,845 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,924,947 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,451,242 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015870174,248$1,518,102
2016865261,404$1,905,293
2017733178,442$1,890,334
2018678249,635$3,054,461
2019668323,904$3,159,899
2020657279,025$3,640,140
2021634214,509$2,803,986
2022629208,363$2,625,845
2023706204,374$2,924,947
2024691172,014$3,451,242

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.8M$3.6M2015 Drug cost: $679,646 (USD; Tot_Drug_Cst)2016 Drug cost: $1,933,409 (USD; Tot_Drug_Cst)2017 Drug cost: $2,259,737 (USD; Tot_Drug_Cst)2018 Drug cost: $2,627,570 (USD; Tot_Drug_Cst)2019 Drug cost: $2,740,349 (USD; Tot_Drug_Cst)2020 Drug cost: $3,038,714 (USD; Tot_Drug_Cst)2021 Drug cost: $3,641,131 (USD; Tot_Drug_Cst)2022 Drug cost: $3,291,566 (USD; Tot_Drug_Cst)2023 Drug cost: $3,121,798 (USD; Tot_Drug_Cst)2024 Drug cost: $3,522,280 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015146667$679,646
20161691,099$1,933,409
20171841,148$2,259,737
20182591,520$2,627,570
20192891,523$2,740,349
20202891,736$3,038,714
20212701,651$3,641,131
20223482,202$3,291,566
20234082,460$3,121,798
20243802,292$3,522,280

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$9.4K$19K2015 Medicare payment: $18,790 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $4,364 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $936 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R11$18,790
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/R45$4,364
2022N/R14$936
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more198324$101
96413Administration of chemotherapy into vein, 1 hour or less132474$99
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more445793$68
36415Insertion of needle into vein for collection of blood sample249467$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count346953$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ErleadaApalutamide291,060$420,925
RevlimidLenalidomide32777$397,335
VerzenioAbemaciclib25700$385,327
IbrancePalbociclib22616$334,456
LenalidomideLenalidomide27728$297,634

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.188$4,496Janssen Biotech, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for David Lecompte Ross, MD?

Tedicare shows public-source Medicare data for David Lecompte Ross, MD (NPI 1912959594), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David Lecompte Ross, MD have ACO affiliation data?

David Lecompte Ross, MD is shown with ACO affiliation data for Primary Care Alliance, LLC (REACH, ACO ID D0010).

What billing organization is linked to David Lecompte Ross, MD?

David Lecompte Ross, MD is linked to CANCER CARE CENTERS OF BREVARD INC (billing NPI 1467551762) in the available physician profile data.

Does David Lecompte Ross, MD have Open Payments data?

David Lecompte Ross, MD has 188 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.